GSK plc (NYSE:GSK) confirmed the sale of 385.3 million shares in Haleon plc (NYSE:HLN) for $1.58 billion. The shares represented around 4.2% of the issued share capital of Haleon. Following the ...
GlaxoSmithKline has introduced a new toothpaste delivery system that disperses active ingredients quickly, penetrating hard-to-reach areas of the mouth, according to the company. Iso-active, which is ...
The share sale and buyback are expected to reduce Pfizer's interest in Haleon from 32% to approximately 24%. In its fourth-quarter release, Haleon added that it expects to allocate £500 million to buy ...
Parodontax, a toothpaste brand, increased its sales across Europe by releasing a creative film to highlight the importance of stopping the journey of gum disease. Parodontax, a toothpaste brand, ...
GlaxoSmithKline has announced that it will transfer production of its Aquafresh and Sensodyne brands from Clifton, NJ, to upstate New York over the next three years, according to a news story in the ...
(Reuters) -Consumer healthcare firm Haleon said on Monday that U.S. drugmaker Pfizer will sell down its stake in the company to about 24%. Pfizer, which currently holds a 32% stake in Haleon, said ...
Haleon has announced that it is launching as an independent company 100% focused on consumer health, completing its demerger from GSK. The newly listed business is driven by its purpose to deliver ...
LONDON (Reuters Breakingviews) - GlaxoSmithKline’s personal health spinoff is beginning life with a target on its back. Haleon, maker of Advil painkillers and Sensodyne toothpaste, will next month ...
GSK PLC completed the spinoff of its consumer-healthcare business, a bet that greater focus on innovative drugs and vaccines will help accelerate growth at the pharmaceuticals giant. The new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results